548 related articles for article (PubMed ID: 34366341)
21. Tau induces inflammasome activation and microgliosis through acetylating NLRP3.
Zhang L; Gai Y; Liu Y; Meng D; Zeng Y; Luo Y; Zhang H; Wang Z; Yang M; Li Y; Liu Y; Lai Y; Yang J; Wu G; Chen Y; Zhu J; Liu S; Yu T; Zeng J; Wang J; Zhu D; Wang X; Lan X; Liu R
Clin Transl Med; 2024 Mar; 14(3):e1623. PubMed ID: 38488468
[TBL] [Abstract][Full Text] [Related]
22. Role of NLRP3 Inflammasome and Its Inhibitors as Emerging Therapeutic Drug Candidate for Alzheimer's Disease: a Review of Mechanism of Activation, Regulation, and Inhibition.
Sharma B; Satija G; Madan A; Garg M; Alam MM; Shaquiquzzaman M; Khanna S; Tiwari P; Parvez S; Iqubal A; Haque SE; Khan MA
Inflammation; 2023 Feb; 46(1):56-87. PubMed ID: 36006570
[TBL] [Abstract][Full Text] [Related]
23. A
Merighi S; Nigro M; Travagli A; Pasquini S; Borea PA; Varani K; Vincenzi F; Gessi S
Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563447
[TBL] [Abstract][Full Text] [Related]
24. Amyloid-β activates NLRP3 inflammasomes by affecting microglial immunometabolism through the Syk-AMPK pathway.
Jung ES; Suh K; Han J; Kim H; Kang HS; Choi WS; Mook-Jung I
Aging Cell; 2022 May; 21(5):e13623. PubMed ID: 35474599
[TBL] [Abstract][Full Text] [Related]
25. NLRP1 Inflammasome Activation in the Hippocampal Formation in Alzheimer's Disease: Correlation with Neuropathological Changes and Unbiasedly Estimated Neuronal Loss.
Španić E; Langer Horvat L; Ilić K; Hof PR; Šimić G
Cells; 2022 Jul; 11(14):. PubMed ID: 35883667
[TBL] [Abstract][Full Text] [Related]
26. NLRP3-dependent microglial training impaired the clearance of amyloid-beta and aggravated the cognitive decline in Alzheimer's disease.
He XF; Xu JH; Li G; Li MY; Li LL; Pei Z; Zhang LY; Hu XQ
Cell Death Dis; 2020 Oct; 11(10):849. PubMed ID: 33051464
[TBL] [Abstract][Full Text] [Related]
27. Aggregated Tau-PHF6 (VQIVYK) Potentiates NLRP3 Inflammasome Expression and Autophagy in Human Microglial Cells.
Panda C; Voelz C; Habib P; Mevissen C; Pufe T; Beyer C; Gupta S; Slowik A
Cells; 2021 Jun; 10(7):. PubMed ID: 34209408
[TBL] [Abstract][Full Text] [Related]
28. MCC950 reduces autophagy and improves cognitive function by inhibiting NLRP3-dependent neuroinflammation in a rat model of Alzheimer's disease.
Naeem A; Prakash R; Kumari N; Ali Khan M; Quaiyoom Khan A; Uddin S; Verma S; Ab Robertson A; Boltze J; Shadab Raza S
Brain Behav Immun; 2024 Feb; 116():70-84. PubMed ID: 38040385
[TBL] [Abstract][Full Text] [Related]
29. Dl-3-n-Butylphthalide Inhibits NLRP3 Inflammasome and Mitigates Alzheimer's-Like Pathology via Nrf2-TXNIP-TrX Axis.
Wang CY; Xu Y; Wang X; Guo C; Wang T; Wang ZY
Antioxid Redox Signal; 2019 Apr; 30(11):1411-1431. PubMed ID: 29634349
[TBL] [Abstract][Full Text] [Related]
30. Myricetin improves pathological changes in 3×Tg-AD mice by regulating the mitochondria-NLRP3 inflammasome-microglia channel by targeting P38 MAPK signaling pathway.
Liu P; Zhou Y; Shi J; Wang F; Yang X; Zheng X; Wang Y; He Y; Xie X; Pang X
Phytomedicine; 2023 Jul; 115():154801. PubMed ID: 37086707
[TBL] [Abstract][Full Text] [Related]
31. A Novel Treatment Strategy by Natural Products in NLRP3 Inflammasome-Mediated Neuroinflammation in Alzheimer's and Parkinson's Disease.
Lee JH; Kim HJ; Kim JU; Yook TH; Kim KH; Lee JY; Yang G
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33525754
[TBL] [Abstract][Full Text] [Related]
32. Modulation of MAPK- and PI3/AKT-Dependent Autophagy Signaling by Stavudine (D4T) in PBMC of Alzheimer's Disease Patients.
La Rosa F; Zoia CP; Bazzini C; Bolognini A; Saresella M; Conti E; Ferrarese C; Piancone F; Marventano I; Galimberti D; Fenoglio C; Scarpini E; Clerici M
Cells; 2022 Jul; 11(14):. PubMed ID: 35883623
[TBL] [Abstract][Full Text] [Related]
33. Edaravone Attenuates the Proinflammatory Response in Amyloid-β-Treated Microglia by Inhibiting NLRP3 Inflammasome-Mediated IL-1β Secretion.
Wang HM; Zhang T; Huang JK; Xiang JY; Chen JJ; Fu JL; Zhao YW
Cell Physiol Biochem; 2017; 43(3):1113-1125. PubMed ID: 28977782
[TBL] [Abstract][Full Text] [Related]
34. GPCR19 Regulates P2X7R-Mediated NLRP3 Inflammasomal Activation of Microglia by Amyloid β in a Mouse Model of Alzheimer's Disease.
Islam J; Cho JA; Kim JY; Park KS; Koh YJ; Chung CY; Lee EJ; Nam SJ; Lee K; Kim SH; Park SH; Lee DY; Kim BC; Lee KH; Seong SY
Front Immunol; 2022; 13():766919. PubMed ID: 35464490
[TBL] [Abstract][Full Text] [Related]
35. The Role of NLRP3 Inflammasome in Alzheimer's Disease and Potential Therapeutic Targets.
Liang T; Zhang Y; Wu S; Chen Q; Wang L
Front Pharmacol; 2022; 13():845185. PubMed ID: 35250595
[TBL] [Abstract][Full Text] [Related]
36. Thioredoxin-Interacting Protein (TXNIP) Associated NLRP3 Inflammasome Activation in Human Alzheimer's Disease Brain.
Li L; Ismael S; Nasoohi S; Sakata K; Liao FF; McDonald MP; Ishrat T
J Alzheimers Dis; 2019; 68(1):255-265. PubMed ID: 30741672
[TBL] [Abstract][Full Text] [Related]
37. Ginkgolide B inhibits NLRP3 inflammasome activation and promotes microglial M2 polarization in Aβ
Zhang Y; Zhao Y; Zhang J; Gao Y; Li S; Chang C; Yu D; Yang G
Neurosci Lett; 2021 Nov; 764():136206. PubMed ID: 34478813
[TBL] [Abstract][Full Text] [Related]
38. AGE-TXNIP axis drives inflammation in Alzheimer's by targeting Aβ to mitochondria in microglia.
Sbai O; Djelloul M; Auletta A; Ieraci A; Vascotto C; Perrone L
Cell Death Dis; 2022 Apr; 13(4):302. PubMed ID: 35379773
[TBL] [Abstract][Full Text] [Related]
39. Inflammasomes as therapeutic targets for Alzheimer's disease.
White CS; Lawrence CB; Brough D; Rivers-Auty J
Brain Pathol; 2017 Mar; 27(2):223-234. PubMed ID: 28009077
[TBL] [Abstract][Full Text] [Related]
40. The role of melatonin in amyloid beta-induced inflammation mediated by inflammasome signaling in neuronal cell lines.
Nopparat C; Boontor A; Kutpruek S; Govitrapong P
Sci Rep; 2023 Oct; 13(1):17841. PubMed ID: 37857668
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
